These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 10681813)

  • 21. Effect of IL-18 and sIL2R on aGVHD occurrence after hematopoietic stem cell transplantation in some Iranian patients.
    Shaiegan M; Iravani M; Babaee GR; Ghavamzadeh A
    Transpl Immunol; 2006 Jan; 15(3):223-7. PubMed ID: 16431290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Effect of 99Tc-MDP on cytokine production by peripheral blood mononuclear cells of patients with rheumatoid arthritis].
    Wu YG; Ma QL; Liu GF
    Hunan Yi Ke Da Xue Xue Bao; 2002 Apr; 27(2):173-5. PubMed ID: 12575354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Serum IL-2 and sIL-2R concentration in children with chronic hepatitis B].
    Pawłowska M; Halota W; Smukalska E; Grabczewska E
    Pol Merkur Lekarski; 2005 Jan; 18(103):33-5. PubMed ID: 15859543
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Soluble interleukin-2 receptor in stage I-III melanoma.
    Ottaiano A; Leonardi E; Simeone E; Ascierto PA; Scala S; Calemma R; Bryce J; Caracò C; Satriano RA; Gianfranco N; Franco R; Botti G; Castello G
    Cytokine; 2006 Feb; 33(3):150-5. PubMed ID: 16517174
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum soluble IL-2 receptor as a marker of lymphocyte activation in some autoimmune diseases. Effect of immunosuppressive therapy.
    Dejica D
    Roum Arch Microbiol Immunol; 2001; 60(3):183-201. PubMed ID: 12165973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Levels of anti-inflammatory cytokines interleukin-2, interleukin-8, and soluble interleukin-2 receptor in blood of patients with various forms of ischemic heart disease].
    Mazurov VI; Stvolov SV; Linetskaia NE; Baldueva IA
    Ter Arkh; 2001; 73(12):14-7. PubMed ID: 11858100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunosuppression follows systemic T lymphocyte activation in the burn patient.
    Teodorczyk-Injeyan JA; Sparkes BG; Mills GB; Peters WJ
    Clin Exp Immunol; 1991 Sep; 85(3):515-8. PubMed ID: 1893634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Detection of interleukin-2 receptor in patients with idiopathic thrombocytopenic purpura].
    Tan B; Zhao X; Yin C
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(2):191-3. PubMed ID: 10681844
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of neuroleptic administration on serum levels of soluble IL-2 receptor-alpha and IL-1 receptor antagonist in schizophrenic patients.
    Sirota P; Meiman M; Herschko R; Bessler H
    Psychiatry Res; 2005 Apr; 134(2):151-9. PubMed ID: 15840416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Serum soluble interleukin-2 receptor levels in patients with renal cell carcinoma: a comparison of values before and after surgery].
    Tsukamoto S; Ishikawa S; Yamauchi A; Saitou S
    Hinyokika Kiyo; 2000 Oct; 46(10):695-9. PubMed ID: 11215193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of N-acetylcysteine in attenuating ischemic reperfusion injury in patients undergoing coronary artery bypass grafting with cardiopulmonary bypass.
    Prabhu A; Sujatha DI; Kanagarajan N; Vijayalakshmi MA; Ninan B
    Ann Vasc Surg; 2009; 23(5):645-51. PubMed ID: 19467834
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aspirin reduces serum anti-melanocyte antibodies and soluble interleukin-2 receptors in vitiligo patients.
    Zailaie MZ
    Saudi Med J; 2005 Jul; 26(7):1085-91. PubMed ID: 16047057
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Change in T cell-mediated immunity and its relationship with high mobility group box-1 protein levels in extensively burned patients].
    Dong N; Jin BQ; Yao YM; Yu Y; Cao YJ; He LX; Chai JK; Sheng ZY
    Zhonghua Wai Ke Za Zhi; 2008 May; 46(10):759-62. PubMed ID: 18953932
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relation of prenephrectomy CD profiles and serum cytokines to the disease outcome and response to IFN-alpha/IL-2 therapy in renal cell carcinoma patients.
    Lauerová L; Dusek L; Spurny V; Simicková M; Rovny A; Rejthar A; Kocák I; Kovarík J
    Oncol Rep; 2001; 8(3):685-92. PubMed ID: 11295103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dose-dependent effect of ethanol on hepatic oxidative stress and interleukin-6 production after burn injury in the mouse.
    Colantoni A; Duffner LA; De Maria N; Fontanilla CV; Messingham KA; Van Thiel DH; Kovacs EJ
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1443-8. PubMed ID: 11003212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Soluble interleukin-2 receptor, intercellular adhesion molecule-1 and interleukin-10 serum levels in patients with melanoma.
    Boyano MD; Garcia-Vázquez MD; López-Michelena T; Gardeazabal J; Bilbao J; Cañavate ML; Galdeano AG; Izu R; Díaz-Ramón L; Raton JA; Díaz-Pérez JL
    Br J Cancer; 2000 Oct; 83(7):847-52. PubMed ID: 10970683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Thermal injury-associated immunosuppression: occurrence and in vitro blocking effect of post recovery serum.
    Ninnemann JL; Fisher JC; Wachtel TL
    J Immunol; 1979 May; 122(5):1736-41. PubMed ID: 448107
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum cytokine profiles in patients with adult onset Still's disease.
    Choi JH; Suh CH; Lee YM; Suh YJ; Lee SK; Kim SS; Nahm DH; Park HS
    J Rheumatol; 2003 Nov; 30(11):2422-7. PubMed ID: 14677188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical evaluation of proinflammatory cytokine inhibitors (sTNFR I, sTNFR II, IL-1 ra), anti-inflammatory cytokines (IL-10, IL-13) and activation of neutrophils after burn-induced inflammation.
    Sikora JP; Chlebna-Sokół D; Andrzejewska E; Chrul S; Polakowska E; Wysocka A; Sikora A
    Scand J Immunol; 2008 Aug; 68(2):145-52. PubMed ID: 18702744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The serum levels of soluble interleukin-2 receptor in patients with malignant lymphocytic proliferative disorders].
    Xu J; Wang B
    Zhonghua Xue Ye Xue Za Zhi; 1998 Feb; 19(2):82-4. PubMed ID: 10921108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.